Bedoradrine

Overview of the drug Bedoradrine

Bedoradrine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Bedoradrine is a beta-adrenergic agonist that has been studied for its potential use in treating asthma and other respiratory diseases. It functions by stimulating beta-2 adrenergic receptors, leading to bronchodilation and improved airflow in the lungs.

Pharmacology

Bedoradrine acts primarily on the beta-2 adrenergic receptors located in the smooth muscle of the bronchi. Activation of these receptors results in the relaxation of bronchial smooth muscle, thereby reducing airway resistance and facilitating easier breathing. This mechanism is similar to that of other beta-2 agonists such as albuterol and salmeterol.

Chemical Structure

Chemical structure of Bedoradrine

Bedoradrine is a synthetic compound with a specific chemical structure that allows it to selectively bind to beta-2 adrenergic receptors. The molecular structure includes a phenethylamine core, which is a common feature among beta-adrenergic agonists.

Clinical Use

While Bedoradrine has shown promise in preclinical studies, it is not currently approved for clinical use. Research is ongoing to determine its efficacy and safety profile in humans. Potential applications include the treatment of chronic obstructive pulmonary disease (COPD) and exercise-induced bronchoconstriction.

Side Effects

As with other beta-2 agonists, potential side effects of Bedoradrine may include tachycardia, tremor, and nervousness. These effects are typically dose-dependent and result from the activation of beta-adrenergic receptors in tissues other than the lungs.

Research and Development

Research into Bedoradrine is focused on optimizing its selectivity and minimizing side effects. Studies are also exploring its potential combination with other respiratory medications to enhance therapeutic outcomes.

Related pages

• Beta-adrenergic agonist
• Asthma
• Chronic obstructive pulmonary disease
• Bronchodilator